ExploreWatchlistsPricing
  1. JP-listed companies
  2. Techno Medica Co., Ltd.
  3. Financials
  4. Stockholders' equity

Techno Medica Co., Ltd. (6678)

Market cap
¥18.4B
P/E ratio
18.8x
Technomedica develops and manufactures clinical laboratory analyzers and medical devices for hospitals and medical facilities worldwide, specializing in automated blood testing systems.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndStockholders' equity (Million JPY)YoY (%)
Mar 31, 202614,410+0.15%
Mar 31, 202514,389+4.13%
Mar 31, 202413,819-15.67%
Mar 31, 202316,387+4.71%
Mar 31, 202215,650+4.61%
Mar 31, 202114,960+5.73%
Mar 31, 202014,149+2.97%
Mar 31, 201913,742+5.56%
Mar 31, 201813,018+6.98%
Mar 31, 201712,169+0.73%
Mar 31, 201612,081+4.34%
Mar 31, 201511,578+10.92%
Mar 31, 201410,438

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat